3-D STRUCTURES OF VIRAL ANTIGEN-ANTIBODY COMPLEXES
病毒抗原-抗体复合物的 3-D 结构
基本信息
- 批准号:3131886
- 负责人:
- 金额:$ 3.92万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1985
- 资助国家:美国
- 起止时间:1985-01-01 至 1991-07-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The aim of this project is to consolidate preliminary studies on
the 3-d structures of influenza virus neuraminidase and of
complexes between two antibody molecules (NC41 and NOlO) and the
influenza virus antigen neuraminidase. It is a continuation of
work supported under NIH grant A121659.
Specifically, three tasks will be undertaken.
(1) The previously determined structure of NC41 Fab-neuraminidase
complex will be defined against the available X-ray diffraction
data to 2.8A resolution. The resulting structure will be analyses
to enable an accurate description of conformational changes in the
neuraminidase which are believed to accompany the binding of this
particular antibody (NC41), and to attempt to find a structural
correlate of the decrease in enzyme activity when the antibody
binds. The refinement will also permit an accurate description of
the V-module quaternary structure in the Fab fragment, which has
been reported to be unusual. Since the uncommon pairing of VL and
VH domains observed in the case of the complexed NC41 antibody
might have been induced by antigen, the detailed differences
between this and other Fab structures may provide some fundamental
insights into immune recognition.
(2) The structure of NClO Fab-neuraminidase complex will be
determined and refined. The findings from this structure will add
to the very small database on antibody-antigen complex structures,
and help to clarify the relative importance of adaptable fitting
versus rigid bonding in the formation of this important class of
macromolecular complexes.
(3) The structures of escape mutants of neuraminidase will be
completed and crystallization experiments with other monoclonal
antibodies and influenza A virus neuraminidases will continue.
The knowledge generated from this work will (a) permit a
description of two overlapping epitopes of this influenza virus
antigen, (b) add to our understanding of antigenic variation in
this and other variable viruses (such as HIV), (c) help to provide
a general understanding of immune recognition, at least as regards
B cell immunity, and (d) aid in the future rational design of
synthetic vaccines.
该项目的目的是巩固关于下列问题的初步研究:
流感病毒神经氨酸酶的三维结构和
两种抗体分子(NC 41和NO10)与抗体分子之间的复合物
流感病毒抗原神经氨酸酶。 这是一个延续,
这项工作得到了NIH资助A121659的支持。
具体而言,将开展三项工作。
(1)先前确定的NC 41 Fab-神经氨酸酶的结构
将根据可用的X射线衍射确定复合物
分辨率为2.8A。 将分析由此产生的结构
为了能够准确地描述蛋白质中的构象变化,
神经氨酸酶,据信伴随着这种结合,
特定抗体(NC 41),并试图找到一个结构
当抗体与酶活性降低相关时,
绑定。 这种改进也将允许准确地描述
Fab片段中的V-模块四级结构,其具有
据报道是不寻常的。 由于VL和
在复合的NC 41抗体的情况下观察到的VH结构域
可能是由抗原引起的,
这种Fab结构和其他Fab结构之间的联系可能会提供一些基本的
对免疫识别的深入了解
(2)NClO Fab-神经氨酸酶复合物的结构将是
坚定而优雅 该结构的发现将增加
到非常小的抗体-抗原复合物结构数据库,
并有助于澄清适应性拟合的相对重要性
相对于刚性键合,
大分子复合物
(3)神经氨酸酶逃逸突变体的结构将是
用其他单克隆抗体完成和结晶实验
抗体和甲型流感病毒神经氨酸酶将继续。
从这项工作中产生的知识将(a)允许
该流感病毒的两个重叠表位的描述
抗原,(B)增加了我们对抗原变异的理解,
这种病毒和其他可变病毒(如艾滋病毒),(c)有助于提供
对免疫识别的一般理解,至少在
B细胞免疫,以及(d)有助于未来合理设计
合成疫苗
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
PETER M COLMAN其他文献
PETER M COLMAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('PETER M COLMAN', 18)}}的其他基金
MYELOID CELL LEUKEMIA PROTEIN 1 BOUND TO BIM-BH3 PEPTIDE
骨髓细胞白血病蛋白 1 与 BIM-BH3 肽结合
- 批准号:
7358882 - 财政年份:2006
- 资助金额:
$ 3.92万 - 项目类别:
3-D STRUCTURES OF VIRAL ANTIGEN-ANTIBODY COMPLEXES
病毒抗原-抗体复合物的 3-D 结构
- 批准号:
3131883 - 财政年份:1985
- 资助金额:
$ 3.92万 - 项目类别:
3-DIMENSIONAL STRUCTURES OF INFLUENZA NEURAMINIDASES
流感神经氨酸酶的三维结构
- 批准号:
3131882 - 财政年份:1985
- 资助金额:
$ 3.92万 - 项目类别:
3-D STRUCTURES OF VIRAL ANTIGEN-ANTIBODY COMPLEXES
病毒抗原-抗体复合物的 3-D 结构
- 批准号:
3131887 - 财政年份:1985
- 资助金额:
$ 3.92万 - 项目类别:
3-DIMENSIONAL STRUCTURES OF INFLUENZA NEURAMINIDASES
流感神经氨酸酶的三维结构
- 批准号:
3131885 - 财政年份:1985
- 资助金额:
$ 3.92万 - 项目类别:
3-DIMENSIONAL STRUCTURES OF INFLUENZA NEURAMINIDASES
流感神经氨酸酶的三维结构
- 批准号:
3131884 - 财政年份:1985
- 资助金额:
$ 3.92万 - 项目类别:
相似海外基金
CAREER: Unveiling the structure and stability of prenucleation clusters and their roles in crystallization pathway and final crystal structure
职业:揭示成核前团簇的结构和稳定性及其在结晶途径和最终晶体结构中的作用
- 批准号:
2338173 - 财政年份:2024
- 资助金额:
$ 3.92万 - 项目类别:
Continuing Grant
CAREER: Nanoscale Resolution of Near-Interface Crystallization in Multicomponent Semicrystalline Polymeric Materials
职业:多组分半晶聚合物材料中近界面结晶的纳米级分辨率
- 批准号:
2338613 - 财政年份:2024
- 资助金额:
$ 3.92万 - 项目类别:
Continuing Grant
CAREER: Evaluating Theories of Polymer Crystallization by Directly Calculating the Nucleation Barrier in a Polymer Melt
职业:通过直接计算聚合物熔体中的成核势垒来评估聚合物结晶理论
- 批准号:
2338690 - 财政年份:2024
- 资助金额:
$ 3.92万 - 项目类别:
Continuing Grant
Anti-solvent crystallization及び ED-Rプロセスを用いる新規LiB再生システムの構築
采用反溶剂结晶和ED-R工艺构建新型LiB再生系统
- 批准号:
24K08133 - 财政年份:2024
- 资助金额:
$ 3.92万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Creation of the active fiber-type device by glass crystallization for next-generation light control
通过玻璃结晶创建用于下一代光控制的有源光纤型装置
- 批准号:
22KJ0290 - 财政年份:2023
- 资助金额:
$ 3.92万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Understanding Plant Based Fat Crystallization for the Design of Vegan and Low Carbon Footprint Chocolate
了解植物脂肪结晶在纯素和低碳足迹巧克力设计中的应用
- 批准号:
BB/Y512692/1 - 财政年份:2023
- 资助金额:
$ 3.92万 - 项目类别:
Training Grant
General applicability and quantitative predictability of complex population-based crystallization models
基于复杂群体的结晶模型的普遍适用性和定量可预测性
- 批准号:
2903595 - 财政年份:2023
- 资助金额:
$ 3.92万 - 项目类别:
Studentship
Elucidation of the origin of zeolite crystallization and innovation of production methods
沸石结晶起源的阐明及生产方法的创新
- 批准号:
23H05454 - 财政年份:2023
- 资助金额:
$ 3.92万 - 项目类别:
Grant-in-Aid for Scientific Research (S)
Biopharmaceuticals purification by continuous membrane-assisted crystallization achieving lower cost and intensified processes (BIOPURE)
通过连续膜辅助结晶进行生物制药纯化,实现更低的成本和强化工艺 (BIOPURE)
- 批准号:
10082780 - 财政年份:2023
- 资助金额:
$ 3.92万 - 项目类别:
EU-Funded
Development of a Novel Method for Producing Pharmaceutical Multi-Phase Solid Using Melt Crystallization
开发利用熔融结晶生产药物多相固体的新方法
- 批准号:
23KJ0860 - 财政年份:2023
- 资助金额:
$ 3.92万 - 项目类别:
Grant-in-Aid for JSPS Fellows